Stepan (SCL) is back in focus after its latest earnings update, paired with Project Catalyst, a two year cost saving plan that includes plant closures, restructuring charges, and an ongoing dividend increase.
See our latest analysis for Stepan.
The share price reaction to Project Catalyst and the recent earnings miss has been sharp, with a 7 day share price return of a 24.3% decline and a 1 year total shareholder return showing a 15.12% loss. This points to fading momentum following a stronger 90 day share price return of 12.27%.
If these moves have you rethinking where you deploy fresh capital, it could be a good moment to look at other materials names through our 8 top copper producer stocks as a starting shortlist.
With the stock down sharply despite Project Catalyst targeting about $100 million of savings and the dividend still moving higher, are you looking at a reset that leaves Stepan undervalued, or a name markets already expect future growth from?
With Stepan closing at $50.89 against a narrative fair value of $75, the current gap rests on a specific set of earnings and margin assumptions.
The startup of the new Pasadena, Texas site is expected to reach full contribution in the second half of 2025, which could boost volume growth and supply chain savings. This is likely to impact revenue and margins positively.
Curious what kind of revenue path and margin reset are baked into that $75 figure? The narrative leans on faster earnings compounding and a future P/E that assumes investors still pay up for this profile. The exact mix of growth, profitability, and required return might surprise you.
Result: Fair Value of $75 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, you still have to weigh headwinds such as weak rigid polyol demand in key regions and ongoing negative free cash flow, which could pressure earnings and cash returns.
Find out about the key risks to this Stepan narrative.
That 32.1% gap to the $75 fair value is built on earnings and P/E assumptions, but the current 24.5x P/E tells a different story. It sits slightly above the US Chemicals industry at 24.1x, below peers at 26.8x, and above a fair ratio of 21.6x, which hints at some valuation risk if sentiment cools. Which signal do you think deserves more weight?
See what the numbers say about this price — find out in our valuation breakdown.
If this mix of potential upside and lingering risks feels finely balanced, it may be helpful to take a closer look now and form your own view with 2 key rewards and 1 important warning sign.
If you want to keep your options open beyond Stepan, this is a smart time to scan for other opportunities that could better fit your goals.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com